These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2543999)

  • 21. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation.
    Brambilla F; Ferrari E; Cavagnini F; Invitti C; Zanoboni A; Massironi R; Catalano M; Cocchi D; Müller EE
    Biol Psychiatry; 1989 Feb; 25(3):256-64. PubMed ID: 2536561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
    Tancer ME; Stein MB; Uhde TW
    Psychoneuroendocrinology; 1990; 15(4):253-9. PubMed ID: 2087535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.
    Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):129-35. PubMed ID: 1934527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
    Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intravenous administration.
    Chapman IM; Willoughby JO
    Neuroendocrinology; 1993 May; 57(5):912-20. PubMed ID: 8105397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM; Mönig H; Mill G; Gödde E; Schulte HM
    Exp Clin Endocrinol Diabetes; 1995; 103(3):205-8. PubMed ID: 7584524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of naloxone and neonatal treatment with monosodium-L-glutamate on growth hormone and prolactin release induced by electrical stimulation of the medial-basal hypothalamus in rats.
    Antoni FA; Kanyicska B; Makara GB
    J Endocrinol; 1983 Mar; 96(3):427-32. PubMed ID: 6833931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological evidence for opioid and adrenergic mechanisms controlling growth hormone, prolactin, pancreatic polypeptide, and catecholamine levels in humans.
    Thompson DA; Pénicaud L; Welle SL; Jacobs LS
    Metabolism; 1985 Apr; 34(4):383-90. PubMed ID: 3982277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute clonidine administration potentiates spontaneous diurnal, but not nocturnal, growth hormone secretion in normal short children.
    Ghigo E; Arvat E; Nicolosi M; Bellone J; Valetto MR; Mazza E; Imperiale E; Procopio M; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):433-5. PubMed ID: 2380338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
    Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):439-44. PubMed ID: 8094392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
    Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C
    Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone responses to dexamethasone in healthy females throughout the menstrual cycle.
    Thakore JH; Dinan TG
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):173-7. PubMed ID: 7704961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum prolactin and growth hormone responses to naloxone and intracerebral ventricle morphine administration in heifers.
    Leshin LS; Rund LA; Thompson FN; Mahaffey MB; Chang WJ; Byerley DJ; Kiser TE
    J Anim Sci; 1990 Jun; 68(6):1656-65. PubMed ID: 2384365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    De Marinis L; Mancini A; D'Amico C; Zuppi P; Tofani A; Della Casa S; Saporosi A; Sambo P; Fiumara C; Calabró F
    Psychoneuroendocrinology; 1991; 16(6):499-504. PubMed ID: 1811245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonadal steroids do not affect basal growth hormone response to naloxone in humans.
    Monteleone P; Maj M; Iovino M; Fiorenza L; Fiumani PM; Steardo L
    Psychopharmacology (Berl); 1987; 93(2):268-70. PubMed ID: 2827218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.